GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enorama Pharma AB (OSTO:ERMA) » Definitions » Receivables Turnover

Enorama Pharma AB (OSTO:ERMA) Receivables Turnover : 3.61 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Enorama Pharma AB Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Enorama Pharma AB's Revenue for the three months ended in Sep. 2024 was kr7.48 Mil. Enorama Pharma AB's average Accounts Receivable for the three months ended in Sep. 2024 was kr2.07 Mil. Hence, Enorama Pharma AB's Receivables Turnover for the three months ended in Sep. 2024 was 3.61.


Enorama Pharma AB Receivables Turnover Historical Data

The historical data trend for Enorama Pharma AB's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enorama Pharma AB Receivables Turnover Chart

Enorama Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.58 0.68 1.82 1.52 1.38

Enorama Pharma AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 1.78 - 3.23 3.61

Competitive Comparison of Enorama Pharma AB's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Enorama Pharma AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enorama Pharma AB's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enorama Pharma AB's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Enorama Pharma AB's Receivables Turnover falls into.



Enorama Pharma AB Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Enorama Pharma AB's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=1.358 / ((1.954 + 0.02) / 2 )
=1.358 / 0.987
=1.38

Enorama Pharma AB's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

Receivables Turnover (Q: Sep. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Sep. 2024 ) / ((Accounts Receivable (Q: Jun. 2024 ) + Accounts Receivable (Q: Sep. 2024 )) / count )
=7.481 / ((1.751 + 2.392) / 2 )
=7.481 / 2.0715
=3.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enorama Pharma AB  (OSTO:ERMA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Enorama Pharma AB Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Enorama Pharma AB's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Enorama Pharma AB Business Description

Traded in Other Exchanges
N/A
Address
Vastra Varvsgatan 19, Malmo, SWE, SE-211 77
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.

Enorama Pharma AB Headlines

No Headlines